Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis

BACKGROUND. The survival benefit of combining sorafenib and transarterial chemoembolization (TACE) therapy compared with sorafenib monotherapy for patients with advanced hepatocellular carcinoma (HCC) and main portal vein tumor thrombosis (MPVTT) is unclear. METHODS. Between January 2009 and June 20...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Zhang, Yingqiang, Fan, Wenzhe, Wang, Yu, Lu, Ligong, Fu, Sirui, Yang, Jianyong, Huang, Yonghui, Yao, Wang, Li, Jiaping
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Hepatobiliary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679083/
https://ncbi.nlm.nih.gov/pubmed/26446238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0196
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados